Gender Dysphoria Market

1. Gender Dysphoria Market Gender dysphoria involves a conflict between a person’s physical or assigned gender and the gender with which he/she identifies. Such people with gender dysphoria often experience significant distress and/or problems functioning associated with this conflict between the way they feel and think of themselves (referred to as experienced or expressed gender) and their physical or assigned gender. DelveInsight’s‘Gender Dysphoria – Market Insights, Epidemiology, and Market Forecast— 2030’ report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of gender dysphoria in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. The gender dysphoria market report provides analysis regarding current treatment practices, market share of the individual therapies, and historical, current, and forecasted gender dysphoria market size from 2017 to 2030, segmented by seven major markets. The report also covers current gender dysphoria treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. Geography Covered    The United States EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan Study Period: 2017–2030 Download request/gender-dysphoria-market sample pages: https://www.delveinsight.com/sample-

2. Gender Dysphoria – Disease Understanding and Treatment Algorithm Overview: People with gender dysphoria feel victims of a biological accident and therefore live their condition as if they were cruelly imprisoned in a body incompatible with their subjective gender identity. GD is associated with clinically significant distress and impairment in social, scholastic, and other vital functioning areas, especially when early-onset is reported. Treatment: Treatment of transgender people often includes four effective medical treatment options: counseling, cross-sex hormones, puberty suppression, and gender reassignment surgery. These treatment is optimally provided by a multidisciplinary team consisting of psychologists, endocrinologists, plastic surgeons, gynecologists, urologists, otorhinolaryngologists, and/or dermatologists. The ever- increasing social acceptance and destigmatization of children and adolescents with GD have resulted in an increased number of transgender individuals seeking endocrine care. The World Professional Association for Transgender Health (WPATH) currently publishes the standards of care (SOC) to provide clinical guidelines for the health care of transsexual, transgender, and gender non-conforming persons to maximize the health and well-being of patients with gender dysphoria. This chapter covers the details of conventional and current medical therapies available for the treatment of gender dysphoria. It also provides the country-wise gender dysphoria treatment guidelines across the United States, Europe, and Japan. DelveInsight’s gender dysphoria market report gives a thorough understanding of the disease by including details such as disease definition, etiology, development, pathophysiology, and diagnosis. It also provides gender dysphoria treatment algorithms and treatment guidelines in the US and Europe. Epidemiology: The Gender Dysphoria epidemiology chapters provide insights about historical and current patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. Gender dysphoria epidemiology is segmented by the total prevalent gender dysphoria cases, the gender- specific prevalence of gender dysphoria, and comorbidities associated with gender dysphoria. In addition, the report includes a thorough analysis of all segments. Two major comorbidities associated with gender dysphoria include suicidal ideation and substance abuse. Amongst the 7MM, patients for suicidal ideation were higher than those of substance abuse. According to DelveInsight’s, the total prevalent population of Gender Dysphoria in seven major markets was 37,241 in 2017. These cases are expected to increase with a significant CAGR during the study period (2017–2030). Among all the seven major markets, the United States accounted for the highest number of gender dysphoria cases. Click here and get access to epidemiology https://www.delveinsight.com/report-store/gender-dysphoria-epidemiology-insight insights of the report:

3. Market Outlook: The market size of Gender Dysphoria is expected to increase at a significant CAGR during the study period (2017–2030). Among all the seven major markets, the United States accounted for the largest market size. Among EU5 countries, UK, in 2017, had the largest market size with USD 19.87 million, while France had the smallest market size of USD 3.74 million. Get useful Market Insights of the report: https://www.delveinsight.com/report-store/gender- dysphoria-market Drugs Uptake: This section focuses on the rate of uptake of therapies that comprise the current treatment landscape in the gender dysphoria market during the study period, 2017–2030. Currently, the mainstay treatment option in the GD treatment landscape is hormonal therapy (HT), which includes feminizing hormone therapies and masculinizing hormone therapies. Combination of antiandrogens (spironolactone), progestin, medroxyprogesterone acetate, GnRH agonists (long-acting gonadotropin-releasing hormone-suppresses testosterone), finasteride, and estrogen (17-beta-estradiol) are the primary revenue-generating components used in the management of transgender women (male to female) and testosterone formulations are employed in case of female to male transition. The analysis covers market uptake by drugs, patient uptake by therapies, and sale of each drug. It helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs, and allows the comparison of the drugs based on market share and size. All of these will help investigate factors important in market uptake and make financial and regulatory decisions. The dynamics of the GD market are currently a consequence of existing therapies, including high- cost surgeries. It can be summarized that basic science and human research efforts will need to be accompanied by translational approaches, where effective novel management methods and strategies are effectively translated from research settings to clinical practice. Request request/gender-dysphoria-market to sample pages: https://www.delveinsight.com/sample-